The overexpression of the co-chaperone BAG3 (BCL2 Associated Athanogene 3) has also been described as associated with pancreatic cancer aggressiveness [59], and its sera levels are measurable in pancreatic cancer patients [45,60]. The gene discussed is BAG3; the disease is pancreatic neoplasm.